Cart
sales@molnova.com
Home - Products - Angiogenesis - FLT - FLT3-IN-2

FLT3-IN-2

CAS No. 923562-23-6

FLT3-IN-2( STK321130 | STK 321130 | STK-321130 | FLT3-IN-2 )

Catalog No. M16613 CAS No. 923562-23-6

FLT3-IN-2 is a FLT3 inhibitor with IC50 of ＜ 1 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 46 In Stock
5MG 71 In Stock
10MG 110 In Stock
25MG 200 In Stock
50MG 332 In Stock
100MG 478 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    FLT3-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    FLT3-IN-2 is a FLT3 inhibitor with IC50 of ＜ 1 μM.
  • Description
    FLT3-IN-2 is a FLT3 inhibitor with IC50 of ＜ 1 μM, detailed information refer to WO 2012158957 A2 and WO 2007013896.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    STK321130 | STK 321130 | STK-321130 | FLT3-IN-2
  • Pathway
    Angiogenesis
  • Target
    FLT
  • Recptor
    FLT3
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    923562-23-6
  • Formula Weight
    416.83
  • Molecular Formula
    C21H16ClF3N4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 30mg/mL
  • SMILES
    FC(C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C43)C=C2)C=C1)(F)F
  • Chemical Name
    5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[4-(trifluoromethyl)phenyl]methyl]-2-pyridinamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang Chao, et al.. From PCT Int. Appl. (2012), WO 2012158957 A2 20121122.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • TG-89

    TG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 μM against JAK2, showing anticancer activity in the treatment of ovarian and cervical cancer.

  • JI6

    JI6 (JAK3 Inhibitor VI) is a potent, selective and orally active FLT3 inhibitor. JI6 exhibits IC50s of ～40, 8, and 4 nM for FLT3-WT, FLT3-D835Y, and FLT3-D835H, respectively.

  • BGB-102

    BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders and malformations.

Sign In Join Free